2-(4-(8-Bromo-2-methyl-1H-imidazo[4,5-c]quinolin-1-yl)phenyl)-2-methylpropanenitrile

Catalog No. :
ACVJBT831
CAS No. :
1624261-99-9
Molecular Formula :
C21H17BrN4
Molecular Weight :
405.30

IUPAC Name:2-(4-(8-bromo-2-methyl-1H-imidazo[4,5-c]quinolin-1-yl)phenyl)-2-methylpropanenitrile

2-(4-(8-Bromo-2-methyl-1H-imidazo[4,5-c]quinolin-1-yl)phenyl)-2-methylpropanenitrile structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
100mg95%$140.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name2-(4-(8-Bromo-2-methyl-1H-imidazo[4,5-c]quinolin-1-yl)phenyl)-2-methylpropanenitrile
IUPAC Name2-(4-(8-bromo-2-methyl-1H-imidazo[4,5-c]quinolin-1-yl)phenyl)-2-methylpropanenitrile
MDL No.MFCD27998190
Molecular FormulaC21H17BrN4
Molecular Weight405.30
SMILESCC(C)(C1=CC=C(N2C(C)=NC3=C2C4=CC(Br)=CC=C4N=C3)C=C1)C#N
InChI KeyFLNZOSVLPXDSKI-UHFFFAOYSA-N
Synonym2-[4-(8-BroMo-2-Methyl-iMidazo[4,5-c]quinolin-1-yl)-phenyl]-2-Methyl-propionitrile;Benzeneacetonitrile, 4-(8-bromo-2-methyl-1H-imidazo[4,5-c]quinolin-1-yl)-α,α-dimethyl-
CAS No.1624261-99-9

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P264-P270-P271-P280-P302+P352-P304+P340-P305+P351+P338-P312-P330-P362-P403+P233-P501

Synthetic Route by SureRoute

1. ACVJBT831 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACVJBT831 route product structure diagram
    ACVJBT8311624261-99-9
Inquiry

2. ACVJBT831 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACCZIU451 route compound structure diagram
    ACCZIU451563-67-7 In Stock
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACVJBT831 route product structure diagram
    ACVJBT8311624261-99-9
Inquiry

Comments (0)